Vorinostat (SAHA)
Product Sizes
50 mg
£134.00
SIH-359-50MG
250 mg
£371.00
SIH-359-250MG
About this Product
- SKU:
- SIH-359
- Additional Names:
- Suberoylanilide-hydroxamic acid; Vorinostat; N-Hydroxy-N'-phenyloctanediamide
- CAS Number:
- 149647-78-9
- CE/IVD:
- Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.
- Extra Details:
- SAHA (Vorinostat) is a potent, cell-permeable HDAC inhibitor with significant implications in neurodegenerative disease research and neuro-oncology. By altering chromatin structure and gene expression, SAHA promotes neuronal differentiation, reduces neuroinflammation, and enhances synaptic function. Its ability to synergize with kinase inhibitors to target CNS tumors also positions it as a promising agent in glioblastoma therapy. Widely cited in oncology for its pro-apoptotic effects, SAHA is increasingly recognized in neuroscience for its role in epigenetic modulation and neuroprotection, making it a valuable compound in translational research.
- Molecular Weight:
- 264.3
- Purity:
- >98%
- Shipping Conditions:
- Ambient
- Source:
- Synthetic
- Storage Conditions:
- -20[o]C
- Supplier:
- StressMarq Biosciences
- Type:
- Proteins, Peptides, Small Molecules & Other Biomolecules: Inhibitors
- Manufacturer's Data Sheet:https://www.stressmarq.com/products/small-molecules/inhibitor/saha-vorinostat-sih-359/
